The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells
Daniela Russo(Target (United States)), Stefania Scala(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 1
Related Papers
Human Melanoma Metastases Express Functional CXCR4
|Clinical Cancer Research|2006|131
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
|Scientific Reports|2015|107
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells
|Cell Death and Disease|2014|80
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
|Journal of Experimental & Clinical Cancer Research|2018|20